NEW YORK, Dec. 10, 2023 /PRNewswire/ — Laboratory information management system (LIMS) market insights – Continue Reading Technavio has announced its latest market research report titled Global Laboratory Information Management System (LIMS) Market 2023-2027 Vendors: 15+, Including Abbott Laboratories, Accelerated Technology Laboratories Inc., Agile Frameworks LLC, Attune Technologies Pvt. Ltd., Autoscribe Informatics, Benchling Inc., Broughton… Continue reading Laboratory information management system (LIMS) market to grow by USD 897.05 million from 2022 to 2023 | Abbott Laboratories, Accelerated Technology Laboratories Inc., Agile Frameworks LLC and more among the key companies in the market -Technavio
Category: Newswire
Savory & Partners: Digital Nomad Visas Sparking a Migration Boom
DUBAI, UAE, Dec. 9, 2023 /PRNewswire/ — The simplicity and lax requirements of digital nomad visas have made them easily accessible, and countries like Portugal and Spain, which have excellent infrastructure, great internet connection, and an outstanding standard of living, draw in more digital nomads by the day, according to experts at Dubai-headquartered citizenship and residency… Continue reading Savory & Partners: Digital Nomad Visas Sparking a Migration Boom
Karyopharm Shares Data at ASH 2023 Showing Strong SVR and TSS Durability Observed from Phase 1 Study of Selinexor 60mg and Ruxolitinib in JAK Inhibitor (JAKi)-Naïve Myelofibrosis Patients, with no SVR or TSS Progressions Observed As of the Data Cutoff(1)
Biomarker Data from Phase 1 Study of Selinexor in Combination with Ruxolitinib in Treatment-Naïve Myelofibrosis (MF) Suggestive of Disease Modification Data Reinforce the Potential for Selinexor in Combination with Ruxolitinib to Become a Novel, First-Line Treatment for JAKi-Naïve Patients with MF NEWTON, Mass., Dec. 10, 2023 /PRNewswire/ — Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical… Continue reading Karyopharm Shares Data at ASH 2023 Showing Strong SVR and TSS Durability Observed from Phase 1 Study of Selinexor 60mg and Ruxolitinib in JAK Inhibitor (JAKi)-Naïve Myelofibrosis Patients, with no SVR or TSS Progressions Observed As of the Data Cutoff(1)
Nona Biosciences Announces Collaboration with Evive Biotech to Accelerate Antibody Discovery
CAMBRIDGE, Mass., Dec. 10, 2023 /PRNewswire/ — Nona Biosciences, a global pioneer of technology innovation and antibody discovery and development solutions, and Evive Biotech, a global biopharmaceutical company devoted to developing a portfolio of novel biological therapies for patients worldwide, today announced a collaboration agreement on antibody discovery based on the Harbour Mice® antibody technology… Continue reading Nona Biosciences Announces Collaboration with Evive Biotech to Accelerate Antibody Discovery
Sustainability Empowerment, Brand Upgrade VIVOTEK among Taiwan’s Best Global Brands
TAIPEI, Dec. 10, 2023 /PRNewswire/ — VIVOTEK (3454TW), the global leading IP surveillance solution provider, has been selected to the Best Taiwan Global Brands, and consistently earned market recognition. The three development engines of operational excellence, comprehensive brand management, and active promotion of sustainable actions, have elevated the brand above competition to display outstanding brand… Continue reading Sustainability Empowerment, Brand Upgrade VIVOTEK among Taiwan’s Best Global Brands
V čínském městě Ču-čou začíná mezinárodní průmyslová výstava International Rail Transit & Equipment Manufacturing Industry Exposition 2023
ČU-ČOU, Čína, 11. prosince 2023 /PRNewswire/ — Ve dnech 8. až 10. prosince se v Mezinárodním kongresovém a výstavním centru v Ču-čou koná Čínská mezinárodní průmyslová výstava železniční přepravy a zařízení 2023 (China International Rail Transit & Equipment Manufacturing Industry Exposition), jejíž součástí je zveřejnění tzv. Siang-ťiangské deklarace o opatřeních pro dosažení dvojího uhlíkového cíle… Continue reading V čínském městě Ču-čou začíná mezinárodní průmyslová výstava International Rail Transit & Equipment Manufacturing Industry Exposition 2023
Xinhua Silk Road: China’s Bama Tea shares tea culture and seeks cooperation at Belt and Road forum
BEIJING, Dec. 10, 2023 /PRNewswire/ — China and Laos share a “tea bond” dating long back and Bama Tea Co., Ltd., with its vision of “Tea for Harmony”, seeks more exchanges with tea producing areas of Laos, as well as cooperation opportunities in areas of innovative product R&D and tea tourism, according to Bama Tea… Continue reading Xinhua Silk Road: China’s Bama Tea shares tea culture and seeks cooperation at Belt and Road forum
Novartis presents new 48-week results from Phase III APPLY-PNH trial showing sustained efficacy and long-term safety of Fabhalta® (iptacopan) in adults with paroxysmal nocturnal hemoglobinuria (PNH)
APPLY-PNH extension data show that continuous Fabhalta® (iptacopan) treatment in adults with paroxysmal nocturnal hemoglobinuria (PNH) enabled sustained hemoglobin-level increases to near-normal (≥12 g/dL), blood transfusion avoidance, and improved patient-reported fatigue in the majority of patients, with a safety profile consistent with previously reported data1-5 Patients switching from anti-C5s to Fabhalta in the extension period… Continue reading Novartis presents new 48-week results from Phase III APPLY-PNH trial showing sustained efficacy and long-term safety of Fabhalta® (iptacopan) in adults with paroxysmal nocturnal hemoglobinuria (PNH)
Международная выставка рельсового транспорта и производства оборудования 2023 г. в Чжучжоу | Китайская международная выставка рельсового транспорта и производства оборудования 2023 года стартует в Чжучжоу
ЧЖУЧЖОУ, Китай, 10 декабря 2023 г. /PRNewswire/ — С 8 по 10 декабря в Международном выставочном центре Чжучжоу проходит Китайская международная выставка рельсового транспорта и производства оборудования 2023 года («Экспо»), на которой будет представлена «Сянцзянская декларация о двухэтапной стратегии достижения углеродной нейтральности в сфере рельсового транспорта». Continue Reading 2023 China International Rail Transit & Equipment… Continue reading Международная выставка рельсового транспорта и производства оборудования 2023 г. в Чжучжоу | Китайская международная выставка рельсового транспорта и производства оборудования 2023 года стартует в Чжучжоу
Antengene Announces the Study of Anti-CD24 Monoclonal Antibody ATG-031 Dosed Its First Patient in the United States
The Phase I PERFORM trial, taking place at four clinical trial centers across the U.S., will evaluate the safety and preliminary efficacy of ATG-031 in patients with advanced solid tumors or B-cell non-Hodgkin’s lymphoma (B-NHL). ATG-031, discovered and developed in-house by Antengene, is the world’s first anti-CD24 antibody to advance to the clinic in oncology.… Continue reading Antengene Announces the Study of Anti-CD24 Monoclonal Antibody ATG-031 Dosed Its First Patient in the United States